Sodium valproate latest
Women still unaware of risks around epilepsy medicines in pregnancy – charity survey finds (07/07/2020)
Clare Pelham Comments On New Sodium Valproate Regulations (30/04/2018)
Sodium Valproate Public Hearing - Summary Report (09/10/2017)
Epilepsy Society's Clare Pelham Discusses Sodium Valproate And EMA Public Hearing On BBC News (18/08/2017)
Public Hearing Into Sodium Valproate - Your Chance To Take Part (13/07/2017)
Sodium Valproate And Women - The Dilemma (16/12/2015)
Government “carefully considering” valproate redress scheme
The House of Lords has discussed the need for a redress scheme for mothers and babies harmed by sodium valproate.
Sodium valproate
Sodium valproate is an epilepsy drug prescribed for all seizure types including absence, myoclonus and tonic clonic seizures. New regulations have been introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) around the way in which the drug, sodium valproate is prescribed to women and girls of childbearing age.
Pregnancy and epilepsy
Most women with epilepsy do not have any change in their seizure frequency during pregnancy. However you might find that your seizures are better controlled during pregnancy, or that you have more seizures than is usual for you.
Epilepsy treatment
If you have just been diagnosed with epilepsy, you may have questions about medication and treatment.
Information from the Medicines and Healthcare Products Regulatory Agency
Read information produced by the MHRA around sodium valproate.